1991
DOI: 10.3109/03630269109072485
|View full text |Cite
|
Sign up to set email alerts
|

The G→A Mutation at Position +22 31to the Cap Site of the β-Globin Gene as a Possible Cause for a β-Thalassemia

Abstract: We describe the occurrence of a chromosome with a G----A mutation at position +22 relative to the Cap site that was found in five patients with beta-thalassemia. All patients had a common type of beta-thalassemia mutation on the second chromosome, namely the frameshift at codon 8 (-AA), the IVS-I-110 (G----A) and the IVS-II-1 (G----A) mutations. The beta genes of two patients, including the 5' and 3' untranslated regions, were completely sequenced and no other mutations, except a few polymorphic sites, were ob… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
31
0

Year Published

2001
2001
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(31 citation statements)
references
References 20 publications
0
31
0
Order By: Relevance
“…We found 11 additional mutations ( Table 2) that were detected by resequencing in known disease-related genes in affected patients (32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42). These uORF-altering mutations were not present in population controls (32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42), and were either the sole mutation detected in the sequenced exons, or were compound heterozygous with a missense/nonsense mutation ( Table 2). The patient presentation was consistent with a recessive phenotype in 3 of the 4 compound heterozygous cases (37, 38, 42, 43), and was ambiguous …”
mentioning
confidence: 98%
“…We found 11 additional mutations ( Table 2) that were detected by resequencing in known disease-related genes in affected patients (32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42). These uORF-altering mutations were not present in population controls (32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42), and were either the sole mutation detected in the sequenced exons, or were compound heterozygous with a missense/nonsense mutation ( Table 2). The patient presentation was consistent with a recessive phenotype in 3 of the 4 compound heterozygous cases (37, 38, 42, 43), and was ambiguous …”
mentioning
confidence: 98%
“…However, a TAF9-independent mode of KLF1 activation is seen at the alpha-hemoglobin stabilizing protein (AHSP) gene, which does not contain a discernible DPE. Together, these interactions with general transcription components are of critical importance for ␤-globin expression, since mutation within TFIIH leads to ␤-thalassemia (26), and some ␤-thalassemia mutations map to the ␤-globin DPE (27,28).…”
mentioning
confidence: 99%
“…Boxed sequences, arrows, and numbering indicate positions of deleterious mutations in each promoter (panels A and C and reference 43). Bases in red indicate the positions of known ␤-thalassemia point mutations in the human ␤-globin promoter (2,8,24,31,57,90), except for ϩ13 (13). Blue-colored bases indicate the sequences representing DCE subelements.…”
Section: Resultsmentioning
confidence: 99%